NZ620436B2 - New sunscreen compositions - Google Patents
New sunscreen compositions Download PDFInfo
- Publication number
- NZ620436B2 NZ620436B2 NZ620436A NZ62043612A NZ620436B2 NZ 620436 B2 NZ620436 B2 NZ 620436B2 NZ 620436 A NZ620436 A NZ 620436A NZ 62043612 A NZ62043612 A NZ 62043612A NZ 620436 B2 NZ620436 B2 NZ 620436B2
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition according
- coral
- filters
- bis
- zooxanthellae
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 230000000475 sunscreen Effects 0.000 title abstract description 18
- 239000000516 sunscreening agent Substances 0.000 title abstract description 18
- 235000014653 Carica parviflora Nutrition 0.000 claims abstract description 45
- 239000004904 UV filter Substances 0.000 claims abstract description 15
- UUGLJVMIFJNVFH-UHFFFAOYSA-N hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1 UUGLJVMIFJNVFH-UHFFFAOYSA-N 0.000 claims abstract description 9
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000132059 Carica parviflora Species 0.000 claims abstract 2
- 239000003205 fragrance Substances 0.000 claims description 25
- 239000006071 cream Substances 0.000 claims description 17
- 239000004334 sorbic acid Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 241000508269 Psidium Species 0.000 claims description 12
- 229940075582 Sorbic Acid Drugs 0.000 claims description 12
- 235000008390 olive oil Nutrition 0.000 claims description 12
- 239000004006 olive oil Substances 0.000 claims description 12
- 235000010199 sorbic acid Nutrition 0.000 claims description 12
- 240000007170 Cocos nucifera Species 0.000 claims description 11
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 11
- 235000013871 bee wax Nutrition 0.000 claims description 11
- 239000012166 beeswax Substances 0.000 claims description 11
- 239000000969 carrier Substances 0.000 claims description 11
- WSWCOQWTEOXDQX-UHFFFAOYSA-N sorbic acid Chemical compound CC=CC=CC(O)=O WSWCOQWTEOXDQX-UHFFFAOYSA-N 0.000 claims description 10
- 235000010701 Lavanda vera Nutrition 0.000 claims description 9
- 240000002809 Lavandula angustifolia Species 0.000 claims description 9
- 235000003515 Lavandula officinalis Nutrition 0.000 claims description 9
- 239000001102 lavandula vera Substances 0.000 claims description 9
- 235000018219 lavender Nutrition 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 239000003755 preservative agent Substances 0.000 claims description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 7
- 230000002335 preservative Effects 0.000 claims description 7
- 240000000560 Citrus x paradisi Species 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000010478 argan oil Substances 0.000 claims description 5
- DSSYKIVIOFKYAU-UHFFFAOYSA-N Camphor Chemical class C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 claims description 4
- 240000007436 Cananga odorata Species 0.000 claims description 4
- 241000378467 Melaleuca Species 0.000 claims description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N TiO Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 4
- 150000008366 benzophenones Chemical class 0.000 claims description 4
- 239000003925 fat Substances 0.000 claims description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910001929 titanium oxide Inorganic materials 0.000 claims description 4
- WBYWAXJHAXSJNI-VOTSOKGWSA-N (2E)-3-phenylprop-2-enoic acid Chemical class OC(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-N 0.000 claims description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 3
- 239000006210 lotion Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- ZUYVPAKYYMBQBT-UHFFFAOYSA-N 3,4-diethyl-2-hexoxyphenol Chemical compound CCCCCCOC1=C(O)C=CC(CC)=C1CC ZUYVPAKYYMBQBT-UHFFFAOYSA-N 0.000 claims 1
- BSUNTQCMCCQSQH-UHFFFAOYSA-N triazine Chemical compound C1=CN=NN=C1.C1=CN=NN=C1 BSUNTQCMCCQSQH-UHFFFAOYSA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 16
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-α-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 abstract description 13
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 abstract description 13
- 229960001295 Tocopherol Drugs 0.000 abstract description 11
- 230000000111 anti-oxidant Effects 0.000 abstract description 11
- 239000003963 antioxidant agent Substances 0.000 abstract description 11
- 235000006708 antioxidants Nutrition 0.000 abstract description 11
- 235000010384 tocopherol Nutrition 0.000 abstract description 11
- 239000011732 tocopherol Substances 0.000 abstract description 11
- 229930003799 tocopherols Natural products 0.000 abstract description 11
- 244000269722 Thea sinensis Species 0.000 abstract description 9
- 235000009569 green tea Nutrition 0.000 abstract description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 9
- 235000020944 retinol Nutrition 0.000 abstract description 8
- 229960003471 retinol Drugs 0.000 abstract description 8
- 239000011607 retinol Substances 0.000 abstract description 8
- 230000036541 health Effects 0.000 abstract description 4
- 241000243321 Cnidaria Species 0.000 description 34
- 150000001875 compounds Chemical class 0.000 description 22
- 241000242757 Anthozoa Species 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 14
- FQUNFJULCYSSOP-UHFFFAOYSA-N Bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 12
- 230000003612 virological Effects 0.000 description 12
- 238000004061 bleaching Methods 0.000 description 9
- 241000894007 species Species 0.000 description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N edta Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 241000700605 Viruses Species 0.000 description 7
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 6
- 241000242733 Acropora Species 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 230000001965 increased Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- XVAMCHGMPYWHNL-UHFFFAOYSA-N Bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 3
- -1 Hydroxyethyl Hydroxyethyl Hydroxyethyl Chemical group 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000001317 epifluorescence microscopy Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 229910000648 terne Inorganic materials 0.000 description 3
- LCULPNBYCKULDR-VGWJSVSZSA-N (6Z)-3-(2-ethylhexoxy)-6-[(4Z)-4-[4-(2-ethylhexoxy)-6-oxocyclohexa-2,4-dien-1-ylidene]-6-(4-methoxyphenyl)-1H-1,3,5-triazin-2-ylidene]cyclohexa-2,4-dien-1-one Chemical compound C1=CC(OCC(CC)CCCC)=CC(=O)\C1=C(/NC(=N\1)C=2C=CC(OC)=CC=2)NC/1=C\1C(=O)C=C(OCC(CC)CCCC)C=C/1 LCULPNBYCKULDR-VGWJSVSZSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-Hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical compound O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 2
- 229940022663 Acetate Drugs 0.000 description 2
- 229960004857 Mitomycin Drugs 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- 206010047461 Viral infection Diseases 0.000 description 2
- 208000001756 Virus Disease Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000001543 one-way ANOVA Methods 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N trans-Retinyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 230000017613 viral reproduction Effects 0.000 description 2
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 240000003917 Bambusa tulda Species 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- 241000565118 Cordylophora caspia Species 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N Ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940116422 PROPYLENE GLYCOL DICAPRATE Drugs 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 206010062080 Pigmentation disease Diseases 0.000 description 1
- 239000004698 Polyethylene (PE) Substances 0.000 description 1
- 206010061529 Polyp Diseases 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N Propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229940111630 Tea Tree Oil Drugs 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N [(2R)-2-[(1S)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2H-furan-4-yl] dihydrogen phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- DWGPSNYAMMWMIW-UHFFFAOYSA-K [5-(1,2-dihydroxyethyl)-2-oxido-4-oxofuran-3-yl] phosphate Chemical compound OCC(O)C1OC([O-])=C(OP([O-])([O-])=O)C1=O DWGPSNYAMMWMIW-UHFFFAOYSA-K 0.000 description 1
- TXKUEILVFFGAIG-UHFFFAOYSA-K [OH-].[OH-].[OH-].[Na+].[Na+].[Na+] Chemical compound [OH-].[OH-].[OH-].[Na+].[Na+].[Na+] TXKUEILVFFGAIG-UHFFFAOYSA-K 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 229940087168 alpha Tocopherol Drugs 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 244000052616 bacterial pathogens Species 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001809 detectable Effects 0.000 description 1
- 231100000415 developmental toxicity Toxicity 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001076 estrogenic Effects 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002101 lytic Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000243 photosynthetic Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 230000002035 prolonged Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000002588 toxic Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 238000004450 types of analysis Methods 0.000 description 1
- 229950004578 vitamin A palmitate Drugs 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000002034 xenobiotic Effects 0.000 description 1
- 239000002676 xenobiotic agent Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A61K8/415—Aminophenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/445—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof aromatic, i.e. the carboxylic acid directly linked to the aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Abstract
The present description refers to eco-compatible compositions for sunscreening the body, in particular to sunscreens for the protection of human health, compatible with organism life and not harmful to marine ecosystems (in particular for tropical environments with coral reefs). In one embodiment the composition comprise one or more UV filters selected from 2,2’-methylene-bis-(6-(2H-benzotriazole-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol, 2-[4-(diethylamine)-2-hydroxybenzoyl]hexyl benzoate, ethylhexyl triazone; and one or more antioxidants selected from tocopheryl acetate, tocopherol, retinol, polyphenolic compounds extracted from green tea. e composition comprise one or more UV filters selected from 2,2’-methylene-bis-(6-(2H-benzotriazole-2-yl)-4-(1,1,3,3-tetramethylbutyl)-phenol, 2-[4-(diethylamine)-2-hydroxybenzoyl]hexyl benzoate, ethylhexyl triazone; and one or more antioxidants selected from tocopheryl acetate, tocopherol, retinol, polyphenolic compounds extracted from green tea.
Description
Trans 12.3
(19.07.2012)
NEW SUNSCREEN COMPOSITIONS
DESCRIPTION
The present description refers to eco-compatible sunscreen compositions, in
ular to sunscreens compatible with the marine environment and the life inhabiting
it, with specific reference to coral reefs.
STATE OF THE PRIOR ART
Coral reefs are among the most biologically productive and e ecosystems
in the world, representing hot spots of marine biodiversity, and directly sustaining half a
billion people (Moberg and Folke 1999, Wilkinson 2004). Approximately 60% of coral
reefs are currently threatened by several natural and anthropogenic impacts s
et al 2003; fi et al 2003). Over the last 20 years, coral bleaching (loss of
symbiotic zooxanthellae hosted within scleractinian corals) has increased ically,
both in frequency and spatial extent -Guldberg 1999; Hughes et al 2003;
Knowlton 2001). This phenomenon has been associated with temperature anomalies,
excess ultraviolet (UV) radiation or altered availability of photosynthetic radiation, and
presence of bacterial pathogens and pollutants (Brown et al 2000; Bruno et al 2007;
Douglas 2003; Glynn 1996; Jones 2004).
Production and consumption of personal care and cosmetic sun products are
increasing worldwide, with potentially important consequences related to environmental
contamination. The release of these products is also linked with the rapid expansion of
tourism in marine coastal areas (Wilkinson 2004). Chemical compounds ned in
sunscreens and other personal care products can reach detectable levels in seawater
ton and Ternes 1999; Giokas et al 2007). These compounds might be
potentially harmful to the environment; hence the use of sunscreen products is now
banned in a few of the most popular tourist destinations, for example, in marine
ks in Mexico (Xcaret 2007; Xel-ha 2007). Because eens are ilic,
their UV filters can accumulate in aquatic animals (Giokas et al, 2007) and cause
effects similar to those reported for other xenobiotic compounds (Balmer et al 2005;
Daughton and Ternes 1999).
Paraben preservatives and some UV absorbers contained in eens have
estrogenic activity (Daughton and Ternes 1999; Schlumpf et al 2004). In addition, it
has been demonstrated that sunscreen ingredients can o various
photodegradations, with the entailed transformation of these agents into toxic by-
products (Giokas et al. 2007, and literature therein). It has also been demonstrated
that sunscreens have an impact on marine bacteria (Danovaro and Corinaldesi 2003).
Recently, a tight onship among sunscreens and bleaching of hard corals was
observed through specific tests worldwide (Danovaro et al. 2008). In particular, in this
In one embodiment there is provided an eco-compatible sunscreen composition comprising:
- one or more UV filters selected from 2,2’-methylene-bis-(6-(2H-benzotriazoleyl)
,3-tetramethylbutyl)-phenol, 2-[4-(diethylamine)hydroxybenzoyl]hexyl te,
ethylhexyl triazone;
- one or more antioxidants selected from tocopheryl acetate, tocopherol, retinol,
polyphenolic compounds extracted from green tea;
- one or more carriers selected from propylene glycol dicaprylate/dicaprate, olive oil,
beeswax;
- one or more fragrances selected from , lavender, grapefruit, guava and coconut,
and free from:
- preservatives belonging to the paraben family;
- ic acid derivatives;
- UV filters selected from bis-ethylhexyloxyphenol methoxyphenyl triazine, ates,
benzophenones, camphor derivatives, titanium oxide;
AH26(10335840_1):RTK
- fragrances selected from melaleuca ial oil, ylang ylang flower extracts, Bambousa
Arundinacea extracts, Karité;
- carriers selected from animal-derived fats and argan oil.
AH26(10335840_1):RTK
Creams; c) Antioxidants; d) UV s; e) Controls.
Figure 5. Coral nubbins at different incubation times. Panels a and b show control
systems at time 0 and after 72 h of incubation. Panels c and d show nubbins of treated
corals at time 0 and after 72 h of incubation.
Figure 6. Photostability of UV-tested filters.
DETAILED PTION OF THE INVENTION
The present invention refers to sunscreen compositions mpatible with
the marine ecosystem of coral reefs.
In the present description, by the definition: “eco-compatible with the marine
ecosystem” of the coral reefs it is meant a product causing no harm nor alteration to
the marine organisms or to the communities or habitats as a whole. An eco-compatible
product is therefore usable without ctions, as it protects the health of environment
and biodiversity. In the tests reported herein, the health conditions of marine
organisms exposed to the various chemical components were verified in order to select
the components absolutely innocuous. Note that a radable product (declaration
associated with some marketed products) can be harmful to the nment and
ore can be not eco-compatible, as the concept of biodegradation refers only to
the decomposition times of the compound.
The compositions of the present invention comprise:
- one or more UV filters selected from MBBT, DHHB and EHT;
- one or more antioxidants selected from eryl acetate, tocopherol, retinol,
polyphenolic compounds extracted from green tea, and which are free from
preservatives belonging to the n family.
In the present description, by ens" are meant the esters of 4-hydroxybenzoic
acid used as preservatives in the cosmetics industry. The most common parabens are
methylparaben, ethylparaben, propylparaben and butylparaben.
An example of polyphenols extracted from green tea is polyphenone—60 (CAS N°
138988-88—2) commercially available from Sigma.
In an embodiment, the compositions of the present invention may comprise one or
more fragrances eco-compatible with the marine environment, selected from the group
consisting of fragrances of orange, lavender, grapefruit, guava and coconut.
Examples of fragrances suitable for the present invention are the nces
commercially available from FAROTTI SRL company, such as guava and coconut,
natural lavender, natural grapefruit, preferably in concentrations equal to or lower than
0.3% of the product.
In order to increase the shelf life times, in an ment the compositions comprise
as vative sorbic acid, which from the testing reported herein did not prove
harmful to coral reefs in conjunction with the other compounds.
The compositions could be prepared in different cosmetic forms, such as, e.g., cream,
lotion, ointment, spray, lipstick. The selected UV s, antioxidants, fragrances and
preservatives could be mixed with different carriers suitable (according to test results)
for the determined cosmetic form that is to be manufactured.
Preferably, carriers having an emollient on will be used, selected in the group
consisting of propylene glycol dicaprylate/dicaprate, olive oil, beeswax.
Propylene glycol dicaprylate/dicaprate (CAS number: 685837) is a derivative of
propylene glycol, and is a r of propylene glycol and fatty acids, In particular, it is
a mixture of ene glycol dicaprylate and propylene glycol dicaprate. This product
is commercially available under the name Labrafac.
Beeswax (CAS number:8012—89—3) suitable for the present invention is e.g.
commercially available under the name Apifil.
The data reported in the experimental section demonstrate that the s MBBT,
DHHB, the antioxidants tocopheryl e and tocopherol and the fragrance of guava
and coconut are the compounds having a greater eco-compatibility with corals.
ably, the compositions of the present invention will therefore comprise MBBT or
DHHB, tocopheryl acetate or Tocopherol and optionally the fragrance of guava and
coconut
The present invention is based on the selection of compounds suitable to be used in
compositions for use as sunscreens compatible with the marine environment and life
inhabiting it, with particular reference to coral reefs.
The majority of compounds commonly used in sunscreens proved harmful to these
nments, compounds such as, e.g.:
- preservatives belonging to the paraben family
- ic acid derivatives;
- UV filters selected from bis ethylhexyloxyphenol methoxyphenyl triazine (BEMT),
cinnamates, benzophenones, camphor derivatives, titanium oxide;
- fragrances selected from melaleuca ial oil, ylang ylang flower extracts,
Bambousa Arundinacea extracts, Karite;
- carriers selected from -derived fats;
- Argan oil.
In an embodiment, the sunscreen compositions comprise:
- one or more UV filters selected from 2,2’-methylene-bis-(6-(2H-benzotriazole-
2—yl)—4-(1,1,3,3-tetramethylbutyl)—phenol, 2—[4-(diethylamine)—2—
hydroxybenzoyl]hexyl benzoate, ethylhexyl triazone;
- one or more idants selected from eryl acetate, tocopherol, retinol,
polyphenolic compounds extracted from green tea;
- one or more rs selected from propylene glycol dicaprylate/dicaprate,
olive oil, beeswax
and are free from:
-preservatives belonging to the paraben family or ic acid derivatives;
-UV filters selected from bis ethylhexyloxyphenol methoxyphenyl triazine,
cinnamates, benzophenones, camphor derivatives, titanium oxide;
-fragrances selected from melaleuca essential oil, ylang ylang flower extracts,
Bambousa Arundinacea extracts, Karite;
-carriers selected from animal-derived fats and argan oil.
In an embodiment with a very high eco-compatibility, they will further comprise sorbic
acid and/or one or more fragrances selected from orange, lavender, ruit, guava
and t.
In a further highly eco-compatible embodiment the compositions are ially
consisting of:
-one or more UV filters selected from 2,2’-methylene-bis-(6-(2H-benzotriazole—
2—yl)—4-(1,1,3,3-tetramethylbutyl)—phenol, 2—[4-(diethylamine)—2—
hydroxybenzoyl]hexyl benzoate, ethylhexyl triazone;
- one or more antioxidants selected from tocopheryl acetate, tocopherol, retinol,
polyphenolic compounds extracted from green tea;
- one or more carriers selected from propylene glycol dicaprylate/dicaprate,
olive oil, beeswax;
- water.
In a further highly eco-compatible embodiment, the compositions are essentially
consisting of:
-one or more UV filters selected from 2,2’-methylene-bis-(6-(2H-benzotriazole—
4-(1,1,3,3-tetramethylbutyl)—phenol, 2—[4-(diethylamine)—2—
hydroxybenzoyl]hexyl benzoate, exyl triazone;
- one or more antioxidants selected from tocopheryl acetate, tocopherol, retinol,
polyphenolic compounds extracted from green tea;
- sorbic acid;
- one or more carriers selected from ene glycol dicaprylate/dicaprate,
olive oil, beeswax;
- water.
In a further ment, the compositions are essentially consisting of:
- 2,2’-methylene-bis-(6-(2H-benzotriazole—2—yl)(1,1,3,3-tetramethylbutyl)—
phenol and/or 2—[4-(diethylamine)hydroxybenzoyl]hexyl benzoate;
- tocopheryl acetate and/or tocopherol;
-sorbic acid;
-one or more carriers selected from propylene glycol dicaprylate/dicaprate, olive
oil, beeswax;
-water;
- one or more fragrances selected from orange, lavender, grapefruit, guava and
coconut
In a r embodiment, the compositions are essentially consisting of:
- 2,2’-methylene—bis-(6-(2H-benzotriazole—2—yl)(1,1,3,3-tetramethylbutyl)—
phenol and/or 2-[4-(diethylamine)hydroxybenzoyl]hexyl benzoate;
- eryl acetate and/or tocopherol;
-sorbic acid;
-one or more carriers selected from propylene glycol ylate/dicaprate, olive
oil, beeswax;
-water;
- one or more fragrances selected from , lavender, ruit, guava and
coconut
- yethyl cellulose and/or EDTA and/or sodium hydroxide.
In a further embodiment, the itions are essentially consisting of:
- 2,2’-methylene—bis-(6-(2H-benzotriazole—2—yl)(1,1,3,3-tetramethylbutyl)—
phenol, 2-[4-(diethylamine)—2—hydroxybenzoyl]hexyl benzoate and ethylhexyl
triazone;
- tocopheryl acetate;
-sorbic acid;
-propylene glycol dicaprylate/dicaprate, olive oil and beeswax;
-water;
- hydroxyethyl ose;
- EDTA;
-sodium hydroxide.
All embodiments listed above are exclusively consisting of compounds tested
individually and as a whole to have a full eco-compatibility with the coral reef and (with
no need of addition of other compounds potentially harmful for the marine ecosystem)
have a high photostability and prolonged storage in a suitable cosmetic formulation.
In the compositions of the present invention, the MBBT, DHHB and EHT could be in a
percentage comprised between 3 and 6% by weight of the composition.
EXAMPLES
The following examples are merely illustrative and do not limit the invention
(e.g., the weighings and concentrations are merely indicative, as the SPFs and the
B absorbance ratios have to be specifically formulated to conform to the
nominal SPFs of the product). Amounts of individual compounds are sed as
weight percentages.
Example 1: In a ic embodiment, the invention has the following formulation in the
form of cream:
APIFIL
LABRAFAC 15.5%
Oliveon
Tocopheryl acetate
Hydroxyethyl cellulose
EDTA 0.05%
Sodium hydroxide 0.4%
Sorbic acid
Guava and coconut 0.3%
H20 remaining %
Examgle 2: In a specific embodiment, the invention has the following formulation in the
form of cream:
Ingredients wlw
MBBT
DHHB
APIFIL
LABRAFAC
Olive oil
Tocopheryl acetate
yethyl ose
EDTA 0.05%
Sodium hydroxide 0.4%
Sorbic acid
Lavender
Example 3: In a specific embodiment, the invention has the following formulation in the
form of cream:
APIFIL
LABRAFAC 13.5%
Olive oil
Tocopheryl acetate
Hydroxyethyl cellulose
EDTA 0.05%
Sodium hydroxide 0.4%
Sorbic acid
Orange
Example 4: preparing the compositions
Compositions are ed by the process described hereinafter:
Phases 1 and 3, indicated in Table 1 are dissolved together at 65°C using a stirrer.
Phase 2 is dissolved separately at the same temperature, always under continuous
stirring. Upon reaching the same temperature, phase 2 is added to phases 1+3 and
the whole is mixed for some minutes at 65°C. To obtain a product having
homogeneous consistency, it is mixed at room temperature and only at the end, then
phase 4 is added. The three compositions thus prepared were tested as described in
the experimental section of the present description.
Table 1. Composition of the 3 preparations of examples 1 ,2 and 3 having a ent
SPF.
-—mmm
Tocopheryl acetate Tocopheryl acetate Tocopheryl acetate Tocopheryl acetate
0.5% 0.5% 0.5% 0.5%
DHHB 4% DHHB 6% DHHB 8%
EHT 1% EHT 2% EHT 3%
MBBT 4% MBBT 6% MBBT 8%
iWater 57.22 Water 53.05 % Water 51.05% Water 49.05%
yethyl Hydroxyethyl Hydroxyethyl Hydroxyethyl
ose 0.2% cellulose 0.2% cellulose 0.2% ose 0.2%
EDTA 0.05% EDTA 0.05% EDTA 0.05% EDTA 0.05%
Sorbic acid 1% Sorbic acid 1% Sorbic acid 1% Sorbic acid 1%
Labrafac 1% Labrafac 1% Labrafac 1% Labrafac 1%
Sodium ide Sodium hydroxide Sodium hydroxide Sodium hydroxide
0.4% 0.4% 0.4% 0.4%
Fragrance 0.3% Fragrance 0.3% Fragrance 0.3% Fragrance 0.3%
OLOGY AND EXPERIMENTAL DATA
3.1. Study area
Field activities were conducted at the Marine y Laboratory of Onong Resort,
Siladen Island, Indonesia. The study area is located in Bunaken National Park,
considered one of the most important Marine Protected Areas in the world. Bunaken
National Park is located in the centre of a reef-building coral ersity triangle, which
roughly asses the Philippines, Indonesia and the Great Barrier Reef. In total,
about 605 zooxanthellate coral species were recorded in the Coral Triangle (Veron et
al., 2009), of which 66% are common to all ecoregions of the area. This diversity
s to 76% of the world’s total species. About 450 coral species have been
described so far in the Indonesian archipelago. Bunaken National Park and nt
waters support diverse hermatypic (reef-building) coral communities, composed of
more than 390 species, 63 genera and 15 families of hard corals, including also some
species yet undescribed. The corals form different community types, broadly
distributed in relation to depth, slope angle and other environmental factors. The area
supports various regionally important populations of a wide array of coral species,
including some 20 species considered to be ly rare. Bunaken National Park
exhibits exceptional levels of within-location diversity. Richest locations host more than
- 30 % of the reef-building coral species complement of the entire Indo-Pacific
region. In particular, in the study area, recent surveys reported that the reef-building
corals accounted for about 90% of total coral species, with highest coral ity
occurring in shallow , likely related to the vely higher habitat geneity
produced by changes in slope angle, re and illumination among other factors,
from the w reef slope to the crest to the reef flat. In the study area, the
occurrence of many endemic species of the genus Acropora were recently reported
ce et al., 2001). Acropora represent one of the larger taxonomic group in the
reefs surrounding Siladen Island. Acropora is the most diverse hermatypic coral genus,
with 114 species recognised ide and 91 species being identified for the
Indonesian archipelago (Wallace, 1999). “Structural species” such as Acropora are a
vital tem component, and variations in their abundance are critical to the
dynamics of entire reef communities (Connell et al., 1997). Acropora spp. plays a
dominant role in the species composition and abundance of many modern day
Indonesian reefs (Suharsono, 1992).
3.2. Experimental design
In situ tests were performed on nubbins (i.e., small branches of about 3-6 cm) of the
stony coral Acropora sp. The nubbins were incubated in microcosms in presence of
known concentrations of various ingredients potentially to be included in the
composition of the eco-compatible sunscreen cream. In particular, coral nubbins
(including more than 3000 polyps each) were collected by scuba divers from the same
colony, d at a depth of about 3 m on the edge of the reef slope. Sampling of
nubbins was performed by means of forceps. The nubbins were washed with seawater
filtered onto 0.02-um filters to ate viruses and prokaryotes. Each microcosm was
prepared with a replicate set of s (n=3) immersed in e polyethylene bags
(Whirl-pack, Nasco, Fort Atkinson, WI, USA) filled with 2 L filtered seawater. A total of
27 microcosms were prepared, in order to test 20 ingredients with the respective
positive and negative controls. The list of treatments, the concentrations of compounds
used and the control systems are reported in Table 2. The osms were incubated
at in situ temperature and light conditions for 72 hours.
Table 2. List of microcosms, treatment types, concentrations of compounds used and
incubation times.
code compound
D-01 Natural grapefruit fragrance
D-02 Tea Tree oil (Mela/euca) fragrance
D-03 YIang-ylang fragrance I
D-04 Natural orange fragrance
D-05 Natural lavender nce
Essencesl
D-06 Argan oil
Fragrances
D-07 Guava & Coconut 22661
D-08 Bamboo 21842
D-09 Karite 20471
D-10 Mare d’inverno 4/381 MC
D-11 Joyful 60029MC
Type-1 base cream
Type-2 base cream Base cream
Type-3 base cream
Alpha-tocopherol (SIGMA code T3251-
idant
DL-tocopherol-acetate (SIGMA code
T3376-5G)
2-phospho-ascorbic acid ium salt
(SIGMA code 49752-10G)
D-19 retinyl palmitate (SIGMA code R3375- 3%
D-20 Retinol (SIGMA code R7632—250MG) 3%
Polyphenol 60 from green tea (SIGMA
D-21 3%
code P1204-25G)
MBBT (filter)
BEMT (filter)
EHT (filter)
DHHB (filter)
Mitomycin C (agent inducing the lytic
cycle in viral infections).
- Control
Both negative and positive control systems (controls) were used. The negative ones
are s in which a substance has been used, the antibiotic mitomycin C, which
triggers viral infections, as it s with use of all creams currently marketed.
Therefore, it serves to indicate the levels of undesired response of a compound. The
positive ones, denoted by BLK PG and BLK, are simply microcosms without addition of
any compound.
Table 3. Concentrations of tested filters
FILTERS Max Low SPF
concentration
MBBT ——-.-
DHHB ——-.-
3.3. ination of viral and rokar otic abundances
Subsamples (15 mL) of seawater nding coral nubbins were collected at the start
of the ment (T0) and after 3 and 6 hours of incubation. After subsampling, sea
water was transferred into sterile test tubes without use of fixatives and stored at -20°C
until laboratory analysis for quantification of viral and prokaryotic abundance. Once in
laboratory, the water samples were immediately sed. Briefly, 200 uL sea water
were diluted 1:10 with prefiltered MilliQ water, through 0.02-um pore filters (Anodisc
filter; 25-mm diameter, Alzos; Whatman) and stained with 20 uL SYBR Green (stock
solution diluted 1:20; lnvitrogen, Carlsbad, CA, USA). Filters were incubated in the
dark for 15 min and mounted on glass slides with a drop of antifade consisting of 50%
phosphate buffer (6.7 mM, pH 7.8) and 50% glycerol containing 0.25% ascorbic acid
(Shibata et al. 2006; Helton et al. 2006; Wen et al. 2004). Slides were stored at -20°C
until microscopy is. Virus and prokaryote counts were obtained by
epifluorescence microscopy fication, X1000; Zeiss Axioplan) by examining at
least 10 optical fields, that is, at least 200 cells or viruses per ate. Viral (and
prokaryotic) enrichment was calculated as ratio between virus (and prokaryote)
abundances and virus (and prokaryote) abundance at the end of the experiment.
3.4 Zooxanthellae counts
Subsamples (50 mL) of seawater surrounding coral nubbins were collected at the start
of the ment (T0) and after 6, 12, 24, 36, 48 and 72 hours of incubation. The
subsamples were fixed in 3% glutaraldehyde and then about 6.0 ml of each replicate
was filtered through 2.0-um polycarbonate filters. Filters were mounted on glass slides
and zooxanthellae counted under epifluorescence microscopy (Zeiss Axioplan, Carl
Zeiss lnc., Jena, Germany; X 400 and X1000) using standard and UV light. Based on
color, autofluorescence and gross cell structure, zooxanthellae released or ted
from nubbins were classified as a) healthy (H, bright yellow color, intact/in good
conditions zooxanthellae; b) pale (P, pale yellow color, vacuolated, partially degraded
zooxanthellae; transparent (T, lacking pigmentations, empty zooxanthellae; Mise and
Hidaka 2003).
3.5 Quantification of coral bleaching
In order to quantify the levels of coral ing (Siebeck et al. 2006) a colorimetric
analysis was performed on digital photographs of corals, taken at the beginning of the
experiment and after 6, 12, 24, 36, 48 and 72 hours of incubation. Photographs were
taken under cal illumination with a Canon PowerShot A620 digital camera (Canon
Inc, Tokyo, Japan) with a scale meter on the background. The photos were
successively analyzed with a photo-editing software (Adobe Photoshop CS2) for color
composition [cyan, a, yellow, black ]. Levels of bleaching were
measured as the difference n the corals' color at the beginning of the
experiment and after ents. Variations in the percentage of the ent color
components (CMYK) were analyzed with one-way analysis of variance (ANOVA). To
rank the bleaching effect due to the compounds tested, a Bray—Curtis similarity matrix
was prepared and a multidimensional scaling analysis of the shifts in CMYK color
ition of treated corals was performed using Primer 5.0 software (Primer-E Ltd.,
Plymouth, UK). Bleaching rates were measured as the dissimilarity percentage in
CMYK color composition between treated and control corals using the SIMPER tool of
Primer 5.0 software (Primer-E Ltd).
4. Results
4.1. Viral and prokaryotic abundance
Viral abundances significantly increased of about 1 order of magnitude during the
incubation experiments. Viral ment ranged from 1.9 to 37.4, in the systems BLK
PG and D08 (Figure 1). Viral abundances at the end of the experiment ranged from
0.44 to 31.2 x 105 viruses ml'1 in systems BLK PG and D15, respectively. yotic
abundances increased of 1-2 orders of magnitude during the incubation experiment.
Prokaryiotes enrichment factors fluctuated within a wide range (Figure 2). The lowest
enrichment factor (1.88) was ed in the BLK PG , whereas in system D11
the enrichment factor was 78.16. A slight reduction of ratios between viral and
prokaryotic abundance (VPR) after incubations was observed in all systems, with the
exception of systems D07 and BLK, where VPR remained stable over time. VPR
sed up to 10 times in system D22.
4.2. Zooxanthellae abundance
At the start of the incubations, in the microcosms no ed zooxanthellae were
found. The number of zooxanthellae increased over time in all microcosms considered.
The final abundance of zooxanthellae found in water surrounding the coral nubbins
ranged from 0.85 to 4.45 x 104 cell ml'1, respectively in systems D11 (inoculated with
Joyful 60029MC) and D18 (inoculated with 2-phospho-L-ascorbic acid ium salt),
(Figure 3 a, b, c, d, e).
In some cases, abundance of released zooxanthellae was lower in systems treated
than in controls. Statistical analyses revealed that only in the case of systems D15,
D16, D17 and D18 the abundance of released cells was significantly higher than in the
BLK system (P<0.01). For all other compounds no significant ences were found
between control and d systems, suggesting that the presence of the compounds
tested in the experimental systems (with the exception of D15, D16, D17 and D18)
causes no increase in the rate of zooxanthellae e from corals.
During microscopic analyses, observed zooxanthellae were split into three main
groups (healthy, pale and transparent) as described in the Materials and methods
section. At the end of the incubations, each group exhibited different abundances in
the water surrounding the coral nubbins (Figure 4). Pale and transparent zooxanthellae
were, in all experimental systems, the dominant , on average representing 44%
and 50% of total released zooxanthellae. Healthy thellae always represented
the lesser fraction, ranging from 0 to 21%.
The low abundance of healthy cells suggests that the incubation time of the
experiments causes a high level of damage to zooxanthellae in all s considered,
negative controls (BLK) included.
4.3. Coral bleaching
In all replicates of every microcosm (control systems included), the release of coral
mucous (comprised of zooxanthellae and coral tissue) was ed within the first 48
h of incubation. This observation is in accordance with the results of the release of
zooxanthellae reported in section 4.2. Mucous release by coral fragments could be
related to the mechanical stress occurred during sampling and preparation of
microcosms. In all microcosms (BLK systems included) after 72 h of incubation a slight
change in color was observed in coral nubbins, potentially occurred as a consequence
of the stress d by incubations. The most evident changes were observed in
systems D18 and MITO, where all 4 color channels were significantly d at the
end of the tions. ln systems D05, D08, and BLK PG, 3 out of 4 color channels
showed alterations. In all other systems, 2 or 1 color channels showed significant
changes. The systems D03, D09, D10, D11, D21, D21 showed changes in 2 color
channels, whereas systems D01, D04, D05, D13, D14, D19, D20 and BLK showed
changes only in 1 color channel. In all other experimental systems, no color changes
were detected in tested s.
4.4 tability of the sunscreen cream exposed to UVA rays (~ 275 kJ/m2)
2 mg cm'2 of cream were spread on glass slides (5 x 5 cm) and exposed to UVA rays.
. UVA absorbance, 320-400 nm (peak corresponding to the DHHB filter) is too
high with respect to the UVB one, 290-320 nm (peak corresponding to the EHT
filter). UVA absorbance should be about 1/3 of the UVB one.
o The spectrum of the wide-spectrum filter, MBBT, is not visible since it has an
extinction coefficient lower than DHHB and EHT, therefore is covered by the
absorbance of the latter. MBBT should appear as a wide spectrum without
m and minimum peaks.
. At the moment, obtained absorbance falls within the range of a sunscreen
cream with a high and low SPF.
. According to the results, it can be ded that the filters are highly
photostable.
4.5 Summary of criteria used to test eco-compatibility of tested products with coral
reefs:
In order to select the most eco-compatible products for each group of compounds (i.e.,
base cream, nce, antioxidants and filters) the following criteria were selected:
1. coral bleaching level;
2. degree of release of symbiotic zooxanthellae;
3. zooxanthellae health conditions;
4. viral enrichment in the incubation medium with respect to controls.
Table 4. Summary of eco-compatible compounds grouped by category.
nd group Ingredients mpatibility
Base cream Type 1 Highly compatible
Type 2 Compatible
Fragrances
Antioxidants
UV filters
Table 5. Viral abundance and enrichment during the incubations. Incubation times
(Incub.), total viral abundances (TVN) and the viral enrichment factor (VEF) are also
reported. Standard deviation values (STD) and variation cients are reported for all
data.
-----_-
-------
-----_-
-------
-----_-
-------
-------
-----_-
-------
mn_-----
-------
-------
-----_-
-------
M_-----
-------
-----_-
-------
-----_-
-------
-----_-
-------
-----_-
-------
-----_-
-----_-
-------
447 _---46
-42h ----
ms _----s-oo
-42h ----
42h ----
_---48
42h ----
_---22
22h ----
_---77
22h ----
_---40
22h ----
_---97
22h ----
_---79
22h ----
MITo _---09
22h ----
BLK _---42
-22h ----
um0-44
-42h ----
Table 6. Bacterial nce (total bacterial number, TBN) during incubations, and
related standard deviations and coefficient of variation.
----_
-----
----_
-----
----_
-----
----_
-----
----_
-----
m_---
-----
----_
-----
----_
-----
M_---
-----
----_
-----
----_
-----
----_
-----
----_
-----
----_
-----
----_
-____
_____
1.42E+06 3.82E+05 2. 70E+01
7E+01
_-99E+01
_-67E+01
_--memo
_-76E+01
_-3oe+01
---_new
Table 7. Number of healthy, pale and arent (i.e., dead) zooxanthellae (in cells
ml'1) released in each microcosm.
Table 8. Percentage of healthy, pale and transparent zooxanthellae ed in the
microcosms.
Systems Total Healthy Pale Trasparent
m m B 5_8 Q
Q m 2 E E
Q m E Q E
M m a E Q
Q m 2 E 7_3
E m 2 fl 5_0
M m 2 fl 5_2
M m Z % Q
Q m m E 2
i m 3 Q E
J m 2 E E
i m é fl 5_9
i m E Q 5_8
m m é fl 5_8
i m 1_ fl fl
i m 2 fl 5_4
m m E 5_2 Q
i m 2 Q E
l m é fl fl
A M Q fl fl
% m 2 fl 5_9
% m é fl 5_8
% m 1 fl 5_4
% m 2 5_4 M
m m 9 a 7_6
% m 2 5_4 fl
BLK PG 100 g Q 5_8
Table 9. Output of one-way ANOVA is for the different color components of
corals. Probability level reported (**=P<0.01; *=P<0.05; NS = not significant).
plecode Cyan (C) genta (M) Yellow (Y) Black (K)
REFERENCE
Balmer M.E., Buser H.R., Muller M.D., Poiger T. (2005). Occurrence of some organic
UV filters in wastewater, in surface waters, and in fish from Swiss lakes. Environmental
Science Technology, 39: 953—962.
Brown B.E., Dunne R.P., Goodson M.S., Douglas A.E. (2000). Marine ecology:
bleaching patterns in reef corals. Nature, 404: 142—143.
Bruno J.F., Selig E.R., Casey K.S., Page C.A., Willis B.L., l CD. (2007).
Thermal stress and coral cover as drivers of coral disease outbreaks. PLoS Biology.
: 1220-1227.
Clarke K.R. & Gorley RN. (2001). PRIMER v5:User manual/tutorial, -E,
Plymouth UK, 91pp.
Conne||, J.H., Hughes T.P., Wallace C.C. (1997). A 30-year study of coral abundance,
recruitment and disturbance at several scales in space and time. ical
Monographs, 67: 461-488.
Danovaro R. & ldesi C. (2003). Sunscreen products increase virus production
through prophage induction in marine ioplankton. Microbial Ecology. 45: 109—
118.
Danovaro R., rni L., Corinaldesi C., Giovannelli D., i E., Astolfi P., Greci
L., Pusceddu A. (2008). Sunscreens cause cora| bleaching by promoting viral
ions. Environmental Health Perspectives. 116: 441-447.
Daughton C.G. & Ternes T.A. (1999). ceuticals and personal care ts in
the environment: agents of subtle change? Environmental Health Perspective. 107:
907—938.
Douglas A.E. (2003). Coral bleaching—how and why? Marine Pollution Bulletin. 46:
385—392.
Giokas D.L., Salvador A., Chisvert A. (2007). UV filters: from sunscreens to human
body and the environment. Trends in Analytical Chemistry. 26: 360—374.
Glynn P.W.(1996). Cora| reef bleaching: facts, hypotheses and implications. Global
Change Biology. 2: 495—509.
Guldberg O. (1999). Climate change, cora| bleaching and the future of the
world’s coral reefs. Marine Freshwater Research. 50: 839—866.
Hughes T.P., Baird A.H., Bellwood D.R., Card M., Connolly SR. (2003). Climate
change, human impacts, and the resilience of coral reefs. Science. 301: 929—933.
Jones R.J. . Testing the ‘photoinhibition’ model of coral bleaching using
chemical tors. Marine Ecology Progress Series. 284: 133—145.
Knowlton N. (2001) . The future of coral reefs. Proceedings of the National Academy of
Sciences of USA. 98: 5419—5425.
Mise T. & Hidaka M. (2003). Degradation of zooxanthellae in the coral Acropora nasuta
during bleaching. a JCRS. 5: 33—39.
Moberg F. & Folke C. (1999). Ecological goods and es of coral reef ecosystems.
ical Economics. 29: 215—233.
Pandolfi J.M., Bradbury R.H., Sala E., Hughes T.P., Bjorndal K.A., Cooke R.G. (2003).
Global trajectories of the long term decline of coral reef ecosystems. Science. 301:
955—958.
Schlumpf M., Schmid P., Durrer S., Conscience M., Maerkel K. (2004). Endocrine
activity and developmental toxicity of cosmetic UV filters-an update. Toxicology. 205:
113—122.
a A., Goto Y., Saito H., Kikuchi T., Toda T., i S. (2006). Comparison of
SYBR Green | and SYBR Gold stains for enumerating bacteria and viruses by
epifluorescence microscopy. Aquatic Microbial Ecology: 43: 223—231.
Suharsono (1992). Coral assemblages around Palau Genteng Besar, Seribu lslands,
lndonesia. In L. M. Chou and CR. Wilkinson (eds.), 3rd ASEAN Science and
Technology Week Conference Proceedings, Vol. 6, Marine Science: Living Coastal
ces, 21-23 Sept. 1992, Singapore, National sity of Singapore. Pp.41-54.
Siebeck U.E., Marshall N.J., Kliiter A., Hoegh-Guldberg O. (2006). ring coral
bleaching using a colour reference card. Coral Reefs. 25: 453—460.
Veron J.E.N., Devantier L.M., Turak E., Green A.L., onth S., Stafford-Smith 8.,
Peterson N. (2009). Delineating the Coral Triangle. Galaxea, l of Coral Reef
Studies 11: 91-100.
Wallace, CC. . Staghorn Corals of the World: A revision of the coral genus
Acropora (Scleractinia; Astrocoeniina; Acroporidae) worldwide, with emphasis on
morphology, phylogeny and biogeography, Pp. 422. rne: CSIRO Publishing.
Wallace C.C., Richards Z., Sharshono (2001). Regional distribution patterns of
Acropora and their use in the conservation of coral reefs in Indonesia.
Wilkinson C. (2004). Status of Coral Reefs of the World: 2004. Townsville, Australia:
Australian Institute for Marine Science.
WE
Claims (12)
- CLAIM : olive oil, beeswax: - one or more fragrances selected from orange, er, grapefruit, guava and coconut, and free from: - preservatives belonging to the paraben family; - ascorbic acid derivatives; - UV filters selected from bis-ethylhexyloxyphenol yphenyl triazine, cinnamates, benzophenones, camphor derivatives, titanium oxide; - nces selected from melaleuca essential oil, ylang ylang flower extracts, Bambousa Arundinacea extracts, Karité; - carriers selected from animal-derived fats and argan oil.
- 2. The composition according to claim 1, further sing sorbic acid.
- 3. The composition according to claim 1, consisting of:
- 4. The composition according to claim 1, consisting of: AH26(10335840_1):RTK
- 5. The ition according to claim 1, consisting of:
- 6. The composition according to claim 1, consisting of:
- 7. The composition according to claim 1, consisting of: AH26(10335840_1):RTK
- 8. The composition according to claim 1, consisting of: - 2,2’-methylene-bis-(6-(2H-benzotriazoleyl)(1,1,3,3-tetramethylbutyl)-phenol, 2-[4-(diethylamine)hydroxybenzoyl]hexyl benzoate and ethylhexyl triazone; - tocopheryl acetate; - sorbic acid; - propylene glycol ylate/dicaprate, olive oil and beeswax; - water; - hydroxyethyl cellulose; - EDTA; - sodium ide; - fragrance selected from lavender or orange or guava and coconut.
- 9. The composition according to any one of claims 1 to 8, wherein said UV filters are present in a concentration comprised between 3 and 6% by weight.
- 10. The composition according to any one of claims 1 to 9, in the form of cream, lotion, ointment, spray, or ck.
- 11. The composition according to any one of claims 1 to 10, characterized in that it is not harmful to the marine environment.
- 12. The composition of claim 11 which is not harmful to coral reefs. Universita Politecnica delle Marche By the Attorneys for the Applicant SPRUSON & FERGUSON Per: AH26(10335840_1):RTK
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000400A ITRM20110400A1 (en) | 2011-07-27 | 2011-07-27 | NEW COMPOSITIONS FOR SOLAR PROTECTION. |
PCT/IB2012/053694 WO2013014584A2 (en) | 2011-07-27 | 2012-07-19 | New sunscreen compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
NZ620436A NZ620436A (en) | 2015-08-28 |
NZ620436B2 true NZ620436B2 (en) | 2015-12-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
He et al. | Comparative toxicities of four benzophenone ultraviolet filters to two life stages of two coral species | |
Tovar-Sánchez et al. | Massive coastal tourism influx to the Mediterranean Sea: The environmental risk of sunscreens | |
Stagos et al. | Correlation of total polyphenolic content with antioxidant and antibacterial activity of 24 extracts from Greek domestic Lamiaceae species | |
AU2012288508B2 (en) | New sunscreen compositions | |
WO2020204198A1 (en) | Cosmetic preparation containing ultraviolet wavelength conversion material and water-soluble thickening agent | |
Rastogi et al. | Analysis of UV-absorbing photoprotectant mycosporine-like amino acid (MAA) in the cyanobacterium Arthrospira sp. CU2556 | |
Milito et al. | From sea to skin: Is there a future for natural photoprotectants? | |
Chatzigianni et al. | Environmental impacts due to the use of sunscreen products: a mini-review | |
US20220079863A1 (en) | Photostable antioxidant cosmetic composition | |
JP2023014168A (en) | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and diol, and cosmetic composition containing the same | |
Varrella et al. | Assessing the eco-compatibility of new generation sunscreen products through a combined microscopic-molecular approach | |
Prakash et al. | A systematic review on occurrence and ecotoxicity of organic UV filters in aquatic organisms | |
Mahanil et al. | Application of phycobiliproteins from Leptolyngbya sp. KC45 for natural illuminated colourant beverages | |
NZ620436B2 (en) | New sunscreen compositions | |
EP2921053A1 (en) | Extracts of Santolina chamaecyparissus | |
ES2557987T3 (en) | Anti-fading composition | |
Class et al. | Inventors: Roberto Danovaro (Ancona, IT) Elisabetta Damiani (Ancona, IT) Cinzia Corinaldesi (Ancona, IT) Assignees: UNIVERSITA'POLITECNICA DELLE MARCHE | |
CN107920517A (en) | Preservative system based on organic acid | |
JP2020525494A (en) | Antibacterial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and aromatic alcohol, and cosmetic composition containing the same | |
JP2006348013A (en) | Composition and method for preventing fading | |
Yakovleva et al. | Ontogenetic change in the abundance of mycosporine-like amino acids in non-zooxanthellate coral larvae | |
Xing et al. | Effects of the ultraviolet filter oxybenzone on physiological responses in a red macroalga, Gracilaria vermiculophylla | |
BR102020017899A2 (en) | Use of viridicatin and viridicatol in the preparation of cosmetic formulations with photoprotective and antioxidant activity and of pharmaceutical formulations for the prevention and/or treatment of inflammatory and parasitic diseases | |
Jyoti et al. | Physiological impact of personal care product constituents on non-target aquatic organisms | |
Lopes et al. | Detoxification and effects of the UV filter Benzophenone-3 in the digestive gland and hemocytes of yellow clam (Amarilladesma mactroides) under a perspective of global warming scenario |